KIM1 and Activin A have been previously studied in AKI, AAV and SLE (10–13), as well as in healthy controls, in whom a reference range of (0.00–398.6 pg./mL) has been proposed for KIM1 (9). This evidence concerns the gene HAVCR1 and acute kidney injury.